A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil
Clinical trial NCT04666675 · WITHDRAWN
Trial details
- NCT number
- NCT04666675
- Sponsor
- AbbVie
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-24
- Primary completion
- 2021-03-23
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.